RSS 2.0Atom
To add an specific blogger’s feed, simply go to their blog and click on their individual RSS link.
Buy Elan before you forget but with a trailing stop loss
Rating: 3.00 (2 votes)
Vote: 
InvestorPlace Blogs is powered by Marketocracy. Marketocracy has authorized Investor Place Blogs as an official registrar for voting through Marketocracy's Investment Research Rating service. Registered members of InvestorPlace Blogs are linked with a Marketocracy account to establish voting power based on their performance of trading and posting on stocks.
Buy Elan before you forget! I've been following Elan Pharmaceuticals for some time but not for their drugs. I used to live in Gwinnett County Georgia and back then Donald Panoz President and Chairman of Elan was buying up land in Gwinnett to build a winery. I visited it from the beginning and really liked the wine. Recently, Elan began coming up on my screeners with a 96% buy on BarCharts. The stock began trading above it's 20, 50 & 100 day moving averages which are part of my required litmus test. When Ken Kam started mentioning the stock I knew I had to look deeper into it. Every place I look there are positive stories, when that happens I start to worry. As boomers approach their 70's they start to worry about quality of life. They see drugs are controlling a lot of the causes for premature death: Weight, Diabetes, High Blood Pressure and Cholesterol. Many of their older relatives and parents are living longer but sliding into a dark hole of forgetfulness and death called Alzheimer's. They are really afraid of this disease more than any other. Elan's trial of Bapineuzumab - nicknamed Bappy may offer protection and cure. Good trial results are all over the news. You may find boomers taking it just because. Here's my caution: I'd buy the stock on it's technicals alone but it really has a story being covered by the news and a product that may have one of the largest markets in history. Why the caution? I've seen press releases before about new wonder drugs. Sometimes later phase trials don't pan out or someone else comes along with an cheaper, more effective drug just when you're about to come to market. I worry that Elan may not be able to dominate market share when this drug goes into production. Buy the stock and ride it on up but PLEASE, PLEASE protect yourself with a trailing stop loss in case the drug gets blind sided by later trial results or competition. | ||
Comments (1)
Thank you for the insight!
Posted by fourwinds | June 30, 2008 7:24 AM